Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles

Bioorganic & Medicinal Chemistry
2009.0

Abstract

The discovery of a series of 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles, dual acting norepinephrine reuptake inhibitors (NRIs) and 5-HT(2A) receptor antagonists, is described. The synthesis and structure-activity relationship (SAR) of this novel series of compounds is also presented.

Knowledge Graph

Similar Paper

Dual acting norepinephrine reuptake inhibitors and 5-HT2A receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles
Bioorganic & Medicinal Chemistry 2009.0
Structure–activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor
Bioorganic & Medicinal Chemistry Letters 2006.0
Studies toward the Discovery of the Next Generation of Antidepressants. 3. Dual 5-HT<sub>1A</sub>and Serotonin Transporter Affinity within a Class ofN-Aryloxyethylindolylalkylamines
Journal of Medicinal Chemistry 2004.0
Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: A new class of selective norepinephrine reuptake inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2008.0
3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2009.0
Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives
Bioorganic &amp; Medicinal Chemistry 2008.0
Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 5
Bioorganic &amp; Medicinal Chemistry Letters 2006.0
Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors
Bioorganic &amp; Medicinal Chemistry Letters 2010.0